Extendicare (TSE:EXE) Price Target Increased to C$9.00 by Analysts at TD Securities

Extendicare (TSE:EXEGet Free Report) had its target price boosted by analysts at TD Securities from C$8.00 to C$9.00 in a research report issued to clients and investors on Wednesday, BayStreet.CA reports. The brokerage presently has a “hold” rating on the stock. TD Securities’ target price points to a potential upside of 9.49% from the company’s previous close.

Separately, Royal Bank of Canada boosted their price objective on Extendicare from C$8.00 to C$8.50 and gave the company a “sector perform” rating in a report on Tuesday, May 21st.

Read Our Latest Stock Report on Extendicare

Extendicare Trading Up 1.1 %

Shares of TSE:EXE traded up C$0.09 on Wednesday, hitting C$8.22. 250,312 shares of the company’s stock were exchanged, compared to its average volume of 124,231. The stock has a market capitalization of C$685.38 million, a price-to-earnings ratio of 20.07 and a beta of 1.26. The business’s 50 day simple moving average is C$7.45 and its two-hundred day simple moving average is C$7.35. Extendicare has a 12 month low of C$5.75 and a 12 month high of C$8.30. The company has a debt-to-equity ratio of 365.69, a current ratio of 0.82 and a quick ratio of 0.98.

Extendicare (TSE:EXEGet Free Report) last issued its quarterly earnings data on Monday, August 12th. The company reported C$0.29 EPS for the quarter. Extendicare had a net margin of 2.63% and a return on equity of 37.03%. The company had revenue of C$348.48 million during the quarter, compared to the consensus estimate of C$360.20 million. Analysts anticipate that Extendicare will post 0.4699088 EPS for the current fiscal year.

Extendicare Company Profile

(Get Free Report)

Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.

See Also

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.